For instance, it has been shown that deregulated FOXM1 expression can confer resistance to chemotherapeutic drugs, such as cisplatin and epirubicin[13], and protect cancer cells against DNA-damage induced cell death in breast cancer[14]. This evidence concerns the gene FOXM1 and cancer.